Busserolles, J., Ben Soussia, I., Pouchol, L., Marie, N., Meleine, M., Devilliers, M., . . . Lolignier, S. (2020). TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects. British Journal of Pharmacology, 177(20), 4782. https://doi.org/10.1111/bph.15243
Chicago Style (17th ed.) CitationBusserolles, Jérôme, et al. "TREK1 Channel Activation as a New Analgesic Strategy Devoid of Opioid Adverse Effects." British Journal of Pharmacology 177, no. 20 (2020): 4782. https://doi.org/10.1111/bph.15243.
MLA (9th ed.) CitationBusserolles, Jérôme, et al. "TREK1 Channel Activation as a New Analgesic Strategy Devoid of Opioid Adverse Effects." British Journal of Pharmacology, vol. 177, no. 20, 2020, p. 4782, https://doi.org/10.1111/bph.15243.